Clinical Trial Update: A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating paliperidone palmitate in schizophrenia patients previously unsuccessfully treated with oral antipsychotics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED